Overview

Topical DHEA Against Vaginal Atrophy

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the dose-response of vaginal mucosa parameters to the local action of DHEA (Dehydroepiandrosterone) in postmenopausal women suffering from vaginal atrophy.

Phase:

Phase 3

Details

Lead Sponsor:

EndoCeutics Inc.

Treatments:

Dehydroepiandrosterone